Shandong Suncadia Medicine Co., Ltd.
Clinical trials sponsored by Shandong Suncadia Medicine Co., Ltd., explained in plain language.
-
New cholesterol drug passes early safety check in 82 healthy adults
Disease control CompletedThis early-stage study tested a new drug called HRS-1301 in 82 healthy adults to see if it is safe and how the body processes it. The goal is to eventually use this drug to help control high cholesterol. Researchers measured side effects and drug levels in blood and urine.
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:31 UTC
-
New drug HRS-7535 shows promise for diabetic kidney disease in phase 2 trial
Disease control CompletedThis study tested a new medicine called HRS-7535 in 281 adults with type 2 diabetes who also have kidney disease. The goal was to see if the drug can improve kidney function and control blood sugar over 16 weeks. Participants took either the drug or a placebo, and researchers mea…
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:28 UTC
-
New diabetes pill shows promise in major trial
Disease control CompletedThis study tested a new drug called HRS-7535 in 284 adults with type 2 diabetes whose blood sugar was not well controlled by diet and exercise alone. Participants received either the drug or a placebo for 32 weeks. The main goal was to see if the drug lowered blood sugar levels (…
Phase: PHASE3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:27 UTC
-
New pill combo aims to slow kidney disease
Disease control CompletedThis study tested two experimental drugs, HRS-1780 and henagliflozin, in 181 adults with chronic kidney disease. The goal was to see if these drugs could reduce protein in the urine, a sign of kidney damage, over 13 weeks. Participants were already on standard blood pressure medi…
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:26 UTC
-
New diabetes drug shows promise in phase 2 trial for patients struggling with current treatments
Disease control CompletedThis study tested a new medicine called HRS-7535 in 155 adults with type 2 diabetes whose blood sugar was not well controlled despite taking metformin and an SGLT2i. Participants received either the new drug or a placebo for 16 weeks. The main goal was to see if HRS-7535 lowers H…
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:17 UTC
-
New obesity drug shows promise in Long-Term weight control
Disease control CompletedThis study looked at the long-term safety and effectiveness of HRS-7535 tablets for weight management in 81 adults with obesity. Participants who completed a previous 36-week study continued treatment for an additional 32 weeks. The main goal was to track side effects, while also…
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
New pill could cut heart risk for those with stubborn high lp(a)
Disease control CompletedThis study tested an oral medication, HRS-5346, in 120 adults with high levels of lipoprotein(a) — a genetic risk factor for heart attacks and strokes. Participants were at high cardiovascular risk and received either the drug or a placebo. The main goal was to see if the drug sa…
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New pain drug HRS-2129 tested in healthy volunteers
Symptom relief CompletedThis early-stage study tested a new drug called HRS-2129 in 23 healthy adults to see if it is safe and how the body processes it. Researchers also measured how the drug affects the ability to feel cold and heat pain. The study is complete, but results are not yet available.
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 03:14 UTC
-
Obesity drug safety check: does HRS-7535 mix well with other meds?
Knowledge-focused CompletedThis study looked at how an experimental drug for obesity (HRS-7535) interacts with four common medicines: acetaminophen (pain relief), digoxin (heart medication), rosuvastatin (cholesterol), and omeprazole (acid reflux). It involved 40 overweight or obese adults aged 18-50. The …
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 03:26 UTC
-
Kidney function may affect how HRS-1893 works in heart disease
Knowledge-focused CompletedThis completed Phase 1 study enrolled 24 adults aged 18-65, including people with mild or moderate kidney impairment and healthy volunteers. Researchers measured how the drug HRS-1893 moves through the body and is cleared, to help determine the right dose for patients with kidney…
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 03:26 UTC
-
Healthy volunteers test diabetes drug cocktail – no cure, just science
Knowledge-focused CompletedThis study looked at how four different diabetes medicines (HRS-1780, henagliflozin, metformin, and HRS-7535) affect each other in the body. It involved 24 healthy men aged 18 to 50. The goal was to measure drug levels and check for side effects, not to treat diabetes. This helps…
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 03:24 UTC
-
Healthy volunteers test new diabetes Pill's absorption under fasting and fed conditions
Knowledge-focused CompletedThis early-stage study enrolled 24 healthy adults to see how different manufacturing methods and food intake affect the absorption of HRS-7535, an experimental drug for type 2 diabetes. Participants took the drug under fasting and fed conditions, and researchers measured drug lev…
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 03:24 UTC
-
Healthy volunteers test diabetes drug combo in Early-Stage study
Knowledge-focused CompletedThis study looked at how two diabetes medications—metformin and an experimental drug called HRS-7535—affect each other's levels in the body. It involved 18 healthy men aged 18 to 50. The goal was purely to measure drug concentrations and safety, not to treat any disease.
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 03:15 UTC
-
Healthy volunteers test new heart Drug's absorption and food effects
Knowledge-focused CompletedThis completed Phase I study involved 38 healthy adults to compare two different tablet forms of HRS-1893, a drug for cardiomyopathy, and to see how food changes the way the body absorbs the drug. Researchers measured drug levels in the blood and monitored safety. The study does …
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 02:48 UTC
-
Healthy volunteers test drug interaction – no cure, just data
Knowledge-focused CompletedThis study looked at how a new drug, HRS-1301, changes the way the body processes rosuvastatin, a common cholesterol-lowering medicine. Sixteen healthy adults took both drugs in a fixed order, and researchers measured drug levels in the blood. The goal was to gather safety and in…
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
Liver function may affect new diabetes Drug's safety
Knowledge-focused CompletedThis study looked at how the body handles HRS-7535, a potential diabetes drug, in people with mild or moderate liver impairment compared to those with normal liver function. 24 adults participated to measure drug levels and safety. The goal is to understand if liver problems chan…
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC
-
Healthy volunteers help test drug safety for future breast cancer therapy
Knowledge-focused CompletedThis study looked at how a drug called itraconazole (used for fungal infections) changes the way the body processes HRS-8080, a potential breast cancer treatment. Sixteen healthy adults took HRS-8080 alone and then with itraconazole to measure drug levels and check for side effec…
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC